≡

Recombinant Matrix Metalloproteinase 14 (MMP14)

MMP-X1; MT1-MMP; MTMMP1; Membrane Inserted; Membrane-type matrix metalloproteinase 1; Membrane-type-1 matrix metalloproteinase

  • Product No.RPC056Hu02
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationMembrane, Cytoplasm
  • Predicted Molecular Mass29.3kDa
  • Accurate Molecular Mass31kDa(Analysis of differences refer to the manual)
  • Residues & TagsAsn322~Ala541 with N-terminal His Tag
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 95%
  • Isoelectric Point6.8
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 216  US$ 540  US$ 1080  US$ 3240  US$ 8100 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Cancer Research Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer Aacrjournals: Source
Anticancer Research Matrix metalloproteinase-2 and -14 in p16-Positive and -Negative HNSCC after Exposure To 5-FU and Docetaxel In Vitro Pubmed:25202075
Endocrine GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes PubMed: 25743265
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC056Hu02 Recombinant Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
RPC056Hu01 Recombinant Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
PAC056Hu01 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14) WB; IHC; ICC; IP.
PAC056Hu02 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14) WB,IHC,ICC/IF
MAC056Hu22 Monoclonal Antibody to Matrix Metalloproteinase 14 (MMP14) WB; IHC; ICC; IP.
SEC056Hu ELISA Kit for Matrix Metalloproteinase 14 (MMP14) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC056Hu Multiplex Assay Kit for Matrix Metalloproteinase 14 (MMP14) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.